BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 25799415)

  • 1. Association between thiopurine S-methyltransferase polymorphisms and thiopurine-induced adverse drug reactions in patients with inflammatory bowel disease: a meta-analysis.
    Liu YP; Wu HY; Yang X; Xu HQ; Li YC; Shi DC; Huang JF; Huang Q; Fu WL
    PLoS One; 2015; 10(3):e0121745. PubMed ID: 25799415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Thiopurine S-Methyltransferase Polymorphisms and Azathioprine-Induced Adverse Drug Reactions in Patients with Autoimmune Diseases: A Meta-Analysis.
    Liu YP; Xu HQ; Li M; Yang X; Yu S; Fu WL; Huang Q
    PLoS One; 2015; 10(12):e0144234. PubMed ID: 26633017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease.
    Dong XW; Zheng Q; Zhu MM; Tong JL; Ran ZH
    World J Gastroenterol; 2010 Jul; 16(25):3187-95. PubMed ID: 20593505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
    Cao Q; Zhu Q; Shang Y; Gao M; Si J
    Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
    Coenen MJ; de Jong DJ; van Marrewijk CJ; Derijks LJ; Vermeulen SH; Wong DR; Klungel OH; Verbeek AL; Hooymans PM; Peters WH; te Morsche RH; Newman WG; Scheffer H; Guchelaar HJ; Franke B;
    Gastroenterology; 2015 Oct; 149(4):907-17.e7. PubMed ID: 26072396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease?
    Fangbin Z; Xiang G; Minhu C; Liang D; Feng X; Min H; Pinjin H
    Ther Drug Monit; 2012 Dec; 34(6):695-701. PubMed ID: 23149442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of thiopurine-S-methyltransferase genotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases.
    Hlavaty T; Batovsky M; Balakova D; Pav I; Celec P; Gregus M; Zakuciova M; Hlista M; Horakova M; Desatova B; Koller T; Toth J; Kadasi L; Huorka M;
    Bratisl Lek Listy; 2013; 114(4):199-205. PubMed ID: 23514552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiopurine methyltransferase gene polymorphisms and activity in Chinese patients with inflammatory bowel disease treated with azathioprine.
    Zhu Q; Cao Q
    Chin Med J (Engl); 2012 Oct; 125(20):3665-70. PubMed ID: 23075721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No induction of thiopurine methyltransferase during thiopurine treatment in inflammatory bowel disease.
    Lindqvist M; Hindorf U; Almer S; Söderkvist P; Ström M; Hjortswang H; Peterson C
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1033-7. PubMed ID: 17065060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New genetic associations in thiopurine-related bone marrow toxicity among inflammatory bowel disease patients.
    Zabala W; Cruz R; Barreiro-de Acosta M; Chaparro M; Panes J; Echarri A; Esteve M; Carpio D; Andreu M; García-Planella E; Domenech E; Carracedo A; Gisbert JP; Barros F;
    Pharmacogenomics; 2013 Apr; 14(6):631-40. PubMed ID: 23570467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of thiopurine S-methyltransferase gene polymorphisms in patients with inflammatory bowel disease from the island of Crete, Greece.
    Coucoutsi C; Emmanouil G; Goulielmos G; Sfakianaki O; Koutroubakis IE; Kouroumalis EA
    Eur J Gastroenterol Hepatol; 2017 Nov; 29(11):1284-1289. PubMed ID: 28857898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiopurine S-methyltransferase (TPMT) genotype does not predict adverse drug reactions to thiopurine drugs in patients with inflammatory bowel disease.
    Gearry RB; Barclay ML; Burt MJ; Collett JA; Chapman BA; Roberts RL; Kennedy MA
    Aliment Pharmacol Ther; 2003 Aug; 18(4):395-400. PubMed ID: 12940924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frequency of serious adverse events of thiopurine treatment in normal thiopurine S-methyltransferase genotype children with inflammatory bowel disease].
    Tárnok A
    Orv Hetil; 2019 Feb; 160(5):179-185. PubMed ID: 30686035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of thiopurine S-methyltransferase activity in patients prescribed thiopurines: a systematic review.
    Booth RA; Ansari MT; Loit E; Tricco AC; Weeks L; Doucette S; Skidmore B; Sears M; Sy R; Karsh J
    Ann Intern Med; 2011 Jun; 154(12):814-23, W-295-8. PubMed ID: 21690596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TPMT and NUDT15 polymorphisms in thiopurine induced leucopenia in inflammatory bowel disease: a prospective study from India.
    Grover N; Bhatia P; Kumar A; Singh M; Lad D; Mandavdhare HS; Samanta J; Prasad KK; Dutta U; Sharma V
    BMC Gastroenterol; 2021 Aug; 21(1):327. PubMed ID: 34425754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of thiopurine metabolite testing and thiopurine methyltransferase determination in pediatric IBD.
    Benkov K; Lu Y; Patel A; Rahhal R; Russell G; Teitelbaum J;
    J Pediatr Gastroenterol Nutr; 2013 Mar; 56(3):333-40. PubMed ID: 23287804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.
    Gearry RB; Barclay ML
    J Gastroenterol Hepatol; 2005 Aug; 20(8):1149-57. PubMed ID: 16048561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications?
    Higgs JE; Payne K; Roberts C; Newman WG
    Pharmacogenomics; 2010 Feb; 11(2):177-88. PubMed ID: 20136357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of thiopurine therapy in paediatric IBD patients.
    De Ridder L; Van Dieren JM; Van Deventer HJ; Stokkers PC; Van der Woude JC; Van Vuuren AJ; Benninga MA; Escher JC; Hommes DW
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1137-41. PubMed ID: 16611274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacogenomics of thiopurine S-methyltransferase.
    Zhou S
    Curr Clin Pharmacol; 2006 Jan; 1(1):119-28. PubMed ID: 18666383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.